In the third installment of our series on immunotherapy, Medical Director Kaylen Jackson describes the two different types of immunotherapy available, active and passive therapies, and the clinical trials currently in progress. For more information on immunotherapy and the clinical trials available, contact us here.
“Hi, I’m Kaylen, and I’m the Medical Outreach Director for The Mesothelioma Center, and today I’m going to be going over immunotherapy and how it works.
The two main classes of immunotherapy treatments include active therapy, which stimulates a response that already exists in the body, and passive therapy, which supplements the body’s own immune system with man-made cell proteins to help it work harder.
Right now there are a number of types of these two classes of immunotherapy in use and being researched including:
Monoclonal antibodies: Monoclonal antibodies are a passive therapy, and the most widely used in immunotherapy. Special disease-fighting man-made proteins called antibodies are manufactured in a lab and then injected into the body to help boost the body’s own immune system functions.
Cancer vaccines: For some reason the body does not recognize cancer cells as foreign. This allows it to fly under the body’s radar and grow unchecked by the immune system. Cancer vaccines work on the premise that the body can be taught to recognize and then attack these cells. This can be achieved by introducing proteins and cells unique to cancer into the body so that it can learn and recognize these responses.
Non-specific immunotherapy: Rather than target specific cells, Non-specific immunotherapy works to boost the body’s overall immune system. This is done by increasing the number of naturally occurring proteins in the body that play a key role in the body’s immune system functions. This can be administered alone, or in conjunction with other therapies.
If you’d like to learn more about immunotherapy and how it works, please give us a call. Tune in next week when I go over how immunotherapy is administered and possible side effects. Thanks for watching, and hope to see you next time.”
Is there a topic you would like to see us discuss? Let us know in the comments below or on Facebook.